Accessibility Menu
 
Baxter International logo

Baxter International

(NYSE) BAX

Current Price$17.13
Market Cap$8.60B
Since IPO (1968)+7,652%
5 Year-78%
1 Year-50%
1 Month-22%

Baxter International Financials at a Glance

Market Cap

$8.60B

Revenue (TTM)

$11.24B

Net Income (TTM)

$957.00M

EPS (TTM)

$-1.68

P/E Ratio

-9.96

Dividend

$0.36

Beta (Volatility)

0.67 (Low)

Price

$17.13

Volume

6,422,044

Open

$16.98

Previous Close

$17.12

Daily Range

$16.45 - $17.23

52-Week Range

$16.08 - $34.52

BAX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Baxter International

Industry

Healthcare Equipment and Supplies

Employees

37,500

CEO

Andrew P. Hider, MBA

Headquarters

Deerfield, IL 60015, US

BAX Financials

Key Financial Metrics (TTM)

Gross Margin

30%

Operating Margin

-3%

Net Income Margin

-9%

Return on Equity

-14%

Return on Capital

-2%

Return on Assets

-5%

Earnings Yield

-10.04%

Dividend Yield

0.02%

Payout Ratio

-36.36%

Stock Overview

Market Cap

$8.60B

Shares Outstanding

514.49M

Volume

6.42M

Short Interest

0.00%

Avg. Volume

10.03M

Financials (TTM)

Gross Profit

$3.38B

Operating Income

$308.00M

EBITDA

$766.00M

Operating Cash Flow

$845.00M

Capital Expenditure

$522.00M

Free Cash Flow

$323.00M

Cash & ST Invst.

$1.97B

Total Debt

$10.00B

Baxter International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.97B

+8.0%

Gross Profit

$577.00M

-39.8%

Gross Margin

19.40%

N/A

Market Cap

$8.60B

N/A

Market Cap/Employee

$226.38K

N/A

Employees

38,000

N/A

Net Income

$1.13B

-120.3%

EBITDA

$447.00M

-154.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.81B

+33.1%

Accounts Receivable

$1.93B

+11.7%

Inventory

$2.23B

+9.1%

Long Term Debt

$9.72B

-8.5%

Short Term Debt

$82.00M

-97.1%

Return on Assets

-4.77%

N/A

Return on Invested Capital

-1.80%

N/A

Free Cash Flow

$444.00M

+26.5%

Operating Cash Flow

$584.00M

+19.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QGENQiagen N.V.
$40.63+2.14%
ATRAptarGroup, Inc.
$125.82+1.35%
MASIMasimo Corporation
$178.09-0.34%
BIOBio-Rad Laboratories, Inc.
$273.60+0.54%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$10.31-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.39+0.02%
UGROUrban-gro
$36.29+4.17%

Questions About BAX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.